Study examines meat consumption’s impact on mortality risk in the frail

Mar­i­nus Phar­ma­ceu­ti­cals is cut­ting about 20% of its work­force and mak­ing oth­er cost-cut­ting changes to ex­tend its cash run­way in­to the first quar­ter of 2025.

The investigational Bruton’s tyrosine kinase (BTK) inhibitor rilzabrutinib was associated with numerical decreases in loss of asthma control events for patients with poorly controlled asthma,